Clinical Trial Update: Safety, Tolerability, and Pharmacokinetics of MK-8266 in Elderly Participants With High Blood Pressure (MK-8266-003) [Phase 1]

View source ↗

Summary

Phase 1 trial assessing safety, tolerability, and pharmacokinetics of MK-8266 in elderly individuals with hypertension; study completed with results posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• MK-8266

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hypertension | Phase 1 | Status: COMPLETED | Results posted: 2018-11-05